Drug Trial Radar · NCT02908958
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Last checked: Nov 19, 2026Latest source record: Jun 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
900
Planned (sponsor's estimate)
Start
Nov 2014
Primary completion
Jun 2017
Sponsor
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- The Children's Hospital of Zhejiang University School of Medicine; The Second Hospital of Anhui Medical University; Guangzhou Women and Children's Medical Center; First People's Hospital of Hangzhou; Qilu Hospital of Shandong University; Zhejiang Provincial People's Hospital; Zhejiang Provincial Hospital of TCM; Central South University; Southwest Hospital, China; First Affiliated Hospital of Guangxi Medical University; Shanghai Children's Medical Center; Second Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Xiamen University; Third Affiliated Hospital, Sun Yat-Sen University; Xiangya Hospital of Central South University; Shaoxing Second Hospital
- First posted
- Sep 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong®) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.
Conditions
- Growth Hormone Deficiency
Interventions
PEG-somatropinBiological
High dose group: PEG Somatropin 0.2 mg/kg/w, subcutaneous use, inject once a week, the duration is for 26 weeks.
PEG-somatropinBiological
Low dose group: PEG Somatropin 0.14 mg/kg/w, subcutaneous use, inject once a week, the duration is for 26 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change of Height Standard Deviation Score for Chronological Age before and after the treatment (ΔHtSDSCA)Time frame: 26 weeks
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Southwest Hospital, Third Military Medical University
Chongqing, China · Recruiting
Shanghai Children's Medical Center
Shanghai, China · Recruiting
The Second Hospital of Anhui Medical University
Hefei, Anhui, China · Recruiting
Wuhu No.1 People's Hospital
Wuhu, Anhui, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China · Recruiting
The Third Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Recruiting
Harbin Children's Hospital
Harbin, Heilongjiang, China · Recruiting
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China · Recruiting
Xiangya Hospital, Central South University
Changsha, Hunan, China · Recruiting
Children's Hospital of Changchun
Changchun, Jilin, China · Recruiting
Qilu Children's Hospital of Shandong University
Jinan, Shandong, China · Recruiting
Qilu Hospital of Shandong University
Jinan, Shandong, China · Recruiting
Chengdu Women and Children's Central Hospital
Chengdu, Sichuan, China · Recruiting
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China · Recruiting
The Children's Hospital ,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Zhejiang Provincial Hospital of Traditional Chinese Medcine Hospital
Hangzhou, Zhejiang, China · Recruiting
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China · Recruiting
Ningbo Women and Children's Hospital
Ningbo, Zhejiang, China · Recruiting
Shaoxing Second Hospital
Shaoxing, Zhejiang, China · Recruiting
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.